Correction to: The design and development of covalent protein-protein interaction inhibitors for cancer treatment

Detalles Bibliográficos
Autores principales: Cheng, Sha-Sha, Yang, Guan-Jun, Wang, Wanhe, Leung, Chung-Hang, Ma, Dik-Lung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7382088/
https://www.ncbi.nlm.nih.gov/pubmed/32709244
http://dx.doi.org/10.1186/s13045-020-00938-7
_version_ 1783563181471301632
author Cheng, Sha-Sha
Yang, Guan-Jun
Wang, Wanhe
Leung, Chung-Hang
Ma, Dik-Lung
author_facet Cheng, Sha-Sha
Yang, Guan-Jun
Wang, Wanhe
Leung, Chung-Hang
Ma, Dik-Lung
author_sort Cheng, Sha-Sha
collection PubMed
description
format Online
Article
Text
id pubmed-7382088
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-73820882020-07-27 Correction to: The design and development of covalent protein-protein interaction inhibitors for cancer treatment Cheng, Sha-Sha Yang, Guan-Jun Wang, Wanhe Leung, Chung-Hang Ma, Dik-Lung J Hematol Oncol Correction BioMed Central 2020-07-24 /pmc/articles/PMC7382088/ /pubmed/32709244 http://dx.doi.org/10.1186/s13045-020-00938-7 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Correction
Cheng, Sha-Sha
Yang, Guan-Jun
Wang, Wanhe
Leung, Chung-Hang
Ma, Dik-Lung
Correction to: The design and development of covalent protein-protein interaction inhibitors for cancer treatment
title Correction to: The design and development of covalent protein-protein interaction inhibitors for cancer treatment
title_full Correction to: The design and development of covalent protein-protein interaction inhibitors for cancer treatment
title_fullStr Correction to: The design and development of covalent protein-protein interaction inhibitors for cancer treatment
title_full_unstemmed Correction to: The design and development of covalent protein-protein interaction inhibitors for cancer treatment
title_short Correction to: The design and development of covalent protein-protein interaction inhibitors for cancer treatment
title_sort correction to: the design and development of covalent protein-protein interaction inhibitors for cancer treatment
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7382088/
https://www.ncbi.nlm.nih.gov/pubmed/32709244
http://dx.doi.org/10.1186/s13045-020-00938-7
work_keys_str_mv AT chengshasha correctiontothedesignanddevelopmentofcovalentproteinproteininteractioninhibitorsforcancertreatment
AT yangguanjun correctiontothedesignanddevelopmentofcovalentproteinproteininteractioninhibitorsforcancertreatment
AT wangwanhe correctiontothedesignanddevelopmentofcovalentproteinproteininteractioninhibitorsforcancertreatment
AT leungchunghang correctiontothedesignanddevelopmentofcovalentproteinproteininteractioninhibitorsforcancertreatment
AT madiklung correctiontothedesignanddevelopmentofcovalentproteinproteininteractioninhibitorsforcancertreatment

Ejemplares similares